Chimerix Inc (NASDAQ: CMRX) is 48.56% higher on its value in year-to-date trading and has touched a low of $0.75 and a high of $5.53 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CMRX stock was last observed hovering at around $5.08 in the last trading session, with the day’s gains setting it 0.09%.
Currently trading at $5.17, the stock is 21.78% and 44.90% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.72 million and changing 1.77% at the moment leaves the stock 228.27% off its SMA200. CMRX registered 349.57% gain for a year compared to 6-month gain of 392.38%.
The stock witnessed a 34.64% loss in the last 1 month and extending the period to 3 months gives it a 501.23%, and is 16.44% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.37% over the week and 6.82% over the month.
Chimerix Inc (CMRX) has around 72 employees, a market worth around $464.97M and $0.16M in sales. Profit margin for the company is -52574.84%. Distance from 52-week low is 589.33% and -6.45% from its 52-week high. The company has generated returns on investments over the last 12 months (-61.28%).
with sales reaching $310.6k over the same period.The EPS is expected to shrink by -6.55% this year, but quarterly earnings will post 189.44% year-over-year. Quarterly sales are estimated to grow 7,665.00% in year-over-year returns.
The shares outstanding are 89.94M, and float is at 76.05M with Short Float at 4.69%.
The top institutional shareholder in the company is RA CAPITAL MANAGEMENT, L.P. with over 8.8 million shares valued at $7.71 million. The investor’s holdings represent 9.818 of the CMRX Shares outstanding. As of 2024-06-30, the second largest holder is MONACO ASSET MANAGEMENT SAM with 4.38 million shares valued at $3.83 million to account for 4.8841 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 4.35 million shares representing 4.8685 and valued at over $3.81 million, while ARMISTICE CAPITAL, LLC holds 2.4813 of the shares totaling 2.22 million with a market value of $1.95 million.
Chimerix Inc (CMRX) Insider Activity
The most recent transaction is an insider sale by Melemed Allen S., the company’s CHIEF MEDICAL OFFICER. SEC filings show that Melemed Allen S. sold 3,065 shares of the company’s common stock on Feb 13 ’25 at a price of $4.50 per share for a total of $13799.0. Following the sale, the insider now owns 0.15 million shares.
Chimerix Inc disclosed in a document filed with the SEC on Feb 13 ’25 that Andriole Michael T. (PRESIDENT AND CEO) sold a total of 7,370 shares of the company’s common stock. The trade occurred on Feb 13 ’25 and was made at $4.52 per share for $33282.0. Following the transaction, the insider now directly holds 0.61 million shares of the CMRX stock.
Still, SEC filings show that on Feb 13 ’25, Alrutz Michael Albert (SVP AND GENERAL COUNSEL) disposed off 1,600 shares at an average price of $4.52 for $7226.0. The insider now directly holds 213,596 shares of Chimerix Inc (CMRX).
